Brief: Viracta Therapeutics Q3 EPS USD -0.33
09/11/2023 13:35
Nov 9 (Reuters) - Viracta Therapeutics Q3 EPS USD -0.33. * Q3 cash & investments USD 63 million * Q3 net income USD -12.6 million
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update